QSAR Modeling of SARS‐CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2-Reference-Cited by-同舟云学术

QSAR Modeling of SARS‐CoV MproInhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2

Published:2020-08-24 Issue:1 Volume:40 Page:2000113
ISSN:1868-1743
Container-title:Molecular Informatics
language:en
Short-container-title:Mol. Inf.

Author:

Alves Vinicius M.¹,Bobrowski Tesia²,Melo‐Filho Cleber C.²,Korn Daniel²³,Auerbach Scott⁴,Schmitt Charles¹,Muratov Eugene N.²⁵^ORCID,Tropsha Alexander²

Affiliation:

1. Office of Data Science National Toxicology Program, NIEHS Morrisville NC 27560 USA

2. Laboratory for Molecular Modeling Division of Chemical Biology and Medicinal Chemistry Beard Hall UNC Eshelman School of Pharmacy University of North Carolina Chapel Hill NC 27599 USA

3. Department of Computer Science University of North Carolina Chapel Hill NC 27599 USA

4. Toxinformatics Group National Toxicology Program, NIEHS Morrisville NC 27560 USA

5. Department of Pharmaceutical Sciences Federal University of Paraiba Joao Pessoa PB Brazil

Funder

National Institutes of Health

Publisher

Wiley

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,Molecular Medicine,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/minf.202000113

Reference64 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2. World Health Organization “Naming the coronavirus disease (COVID-19) and the virus that causes it ” Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it Accessed Jun 26 2020 2020.

3. World Health Organization “Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) ” Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) Accessed Jun 26 2020 2020.

4. Worldwide Reduction in MERS Cases and Deaths since 2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved SAR and QSAR models of SARS-CoV-2 Mpro inhibitors based on machine learning;Journal of Molecular Liquids;2024-01

2. Small molecule antiviral compound collection (SMACC): A comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules;Antiviral Research;2023-09

3. HDAC6 detector: online application for evaluating compounds as potential histone deacetylase 6 inhibitors;SAR and QSAR in Environmental Research;2023-08-03

4. The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study;Frontiers in Drug Discovery;2023-07-25

5. Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro;Frontiers in Pharmacology;2023-06-22